Nikoleta Psatha
Nikoleta Psatha
Altius Scholar, Altius Institute for Biomedical Sciences
Verified email at altius.org
Title
Cited by
Cited by
Year
Functional footprinting of regulatory DNA
J Vierstra, A Reik, KH Chang, S Stehling-Sun, Y Zhou, SJ Hinkley, ...
Nature methods 12 (10), 927-930, 2015
1182015
Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and …
E Yannaki, T Papayannopoulou, E Jonlin, F Zervou, G Karponi, ...
Molecular Therapy 20 (1), 230-238, 2012
582012
Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and …
E Yannaki, T Papayannopoulou, E Jonlin, F Zervou, G Karponi, ...
Molecular Therapy 20 (1), 230-238, 2012
582012
Plerixafor+G-CSF–mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy
G Karponi, N Psatha, CW Lederer, JE Adair, F Zervou, N Zogas, ...
Blood, The Journal of the American Society of Hematology 126 (5), 616-619, 2015
432015
Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with β-thalassemia major
N Psatha, A Reik, S Phelps, Y Zhou, D Dalas, E Yannaki, DN Levasseur, ...
Molecular Therapy-Methods & Clinical Development 10, 313-326, 2018
272018
HDAd5/35++ adenovirus vector expressing anti-CRISPR peptides decreases CRISPR/Cas9 toxicity in human hematopoietic stem cells
C Li, N Psatha, S Gil, H Wang, T Papayannopoulou, A Lieber
Molecular Therapy-Methods & Clinical Development 9, 390-401, 2018
262018
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
C Li, N Psatha, P Sova, S Gil, H Wang, J Kim, C Kulkarni, C Valensisi, ...
Blood 131 (26), 2915-2928, 2018
232018
A combined in vivo HSC transduction/selection approach results in efficient and stable gene expression in peripheral blood cells in mice
H Wang, M Richter, N Psatha, C Li, J Kim, J Liu, A Ehrhardt, SK Nilsson, ...
Molecular Therapy-Methods & Clinical Development 8, 52-64, 2018
192018
Optimizing autologous cell grafts to improve stem cell gene therapy
N Psatha, G Karponi, E Yannaki
Experimental hematology 44 (7), 528-539, 2016
192016
In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia
H Wang, A Georgakopoulou, N Psatha, C Li, C Capsali, HB Samal, ...
The Journal of clinical investigation 129 (2), 598-615, 2019
152019
Integrating HDAd5/35++ vectors as a new platform for HSC gene therapy of hemoglobinopathies
C Li, N Psatha, H Wang, M Singh, HB Samal, W Zhang, A Ehrhardt, ...
Molecular Therapy-Methods & Clinical Development 9, 142-152, 2018
152018
Mobilization of hematopoietic stem cells in a thalassemic mouse model: implications for human gene therapy of thalassemia
E Yannaki, N Psatha, E Athanasiou, G Karponi, V Constantinou, ...
Human gene therapy 21 (3), 299-310, 2010
142010
Brief report: a differential transcriptomic profile of ex vivo expanded adult human hematopoietic stem cells empowers them for engraftment better than their surface phenotype
N Psatha, G Georgolopoulos, S Phelps, T Papayannopoulou
Stem cells translational medicine 6 (10), 1852-1858, 2017
102017
Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbbth-3 Mouse Model
N Psatha, E Sgouramali, A Gkountis, A Siametis, P Baliakas, ...
Human gene therapy methods 25 (6), 317-327, 2014
102014
Genetics of the peloponnesean populations and the theory of extinction of the medieval peloponnesean Greeks
G Stamatoyannopoulos, A Bose, A Teodosiadis, F Tsetsos, A Plantinga, ...
European Journal of Human Genetics 25 (5), 637-645, 2017
92017
Clinical-scale genome editing of the human BCL11A erythroid enhancer for treatment of the hemoglobinopathies
FD Urnov, A Reik, J Vierstra, KH Chang, Y Zhou, A Mich, J Adrian, L Fox, ...
Blood, The Journal of the American Society of Hematology 126 (23), 204-204, 2015
82015
A new era for hemoglobinopathies: more than one curative option
N Psatha, PG Papayanni, E Yannaki
Current gene therapy 17 (5), 364-378, 2017
52017
53. From GWAS To the Clinic: Genome-Editing the Human BCL11A Erythroid Enhancer for Fetal Globin Elevation in the Hemoglobinopathies
A Reik, KH Chang, J Vierstra, N Psatha, S Stehling-Sun, Y Zhou, ...
Molecular Therapy 23, S23-S24, 2015
32015
Unbiased phenotypic identification of functionally distinct hematopoietic progenitors
G Georgolopoulos, M Iwata, N Psatha, M Yiangou, J Vierstra
Journal of Biological Research-Thessaloniki 26 (1), 4, 2019
22019
Introduction of two simultaneous mutations by genome editing greatly enhances the accumulation of the endogenous fetal hemoglobin in human normal erythroid cells
N Psatha, C Li, H Wang, D Dalas, G Stamatoyannopoulos, ...
Blood 130 (Supplement 1), 947-947, 2017
22017
The system can't perform the operation now. Try again later.
Articles 1–20